Global Approach to Faint and Falls

Launched by ISTITUTO AUXOLOGICO ITALIANO · Feb 21, 2023

Keywords

ClinConnect Summary

The "Global Approach to Faint and Falls" clinical trial is studying how to better diagnose and manage patients who experience fainting (syncope) or unexplained falls. These events are especially common in older adults, and understanding why they happen is important to prevent future incidents. The trial aims to see if following a specific set of guidelines for testing and treatment can improve patient care and reduce costs associated with unnecessary hospital visits and tests.

To be eligible for this study, participants must be at least 40 years old and have been referred to a specialized clinic for evaluation of fainting or falls. Those with a known diagnosis of syncope or who have falls due to serious underlying health issues will not be included. If you decide to participate, you can expect to undergo a series of tests to help determine the cause of your symptoms, and the trial will carefully track the effectiveness of the approach used. This research could lead to better care for many patients who face these challenges.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Consecutive patients aged ≥40 years referred to the Faint \& Fall Clinics for assessment of an episode of faint or fall.
• Exclusion Criteria:
• • Patients with age \<40 years
• • Patients with incidental fall
• • Patients with an established diagnosis of syncope
• • Patients in whom syncope and fall are secondary symptoms of severe underlying comorbidities (e.g: acute myocardial infarction, pulmonary embolism, acute haemorrage)